Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
Patients with type 2 diabetes mellitus (DM) and those with impaired glucose tolerance are at increased risk for the development of cardiovascular disease. With an increasing global incidence and prevalence of type 2 DM, and with the 2003 lowering of the glucose threshold required for the diagnosis o...
Prif Awduron: | Bethel, M, Califf, R |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2007
|
Eitemau Tebyg
-
Treatment of diabetes mellitus: implications of the use of oral agents.
gan: Rao, S, et al.
Cyhoeddwyd: (1999) -
Lifestyle Modification in the Prevention of Type II Diabetes Mellitus
gan: Muhammad Umair Khan
Cyhoeddwyd: (2012-03-01) -
Oral agent therapy in the treatment of type 2 diabetes.
gan: Feinglos, M, et al.
Cyhoeddwyd: (1999) -
The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus
gan: Hala Zakaria, et al.
Cyhoeddwyd: (2023-02-01) -
The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents.
gan: Dante S Harbuwono, et al.
Cyhoeddwyd: (2020-01-01)